Clinical Trial Update: LTX-109 as Treatment for Hidradenitis Suppurativa [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for LTX-109 in hidradenitis suppurativa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• LTX-109

Snippet

Sponsor: Pharma Holdings AS | Conditions: Hidradenitis Suppurativa | Phase 1, Phase 2 | Status: COMPLETED